S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Merrimack Pharmaceuticals to Regain Worldwide Rights to Develop and Commercialize MM-121|
|Phase III FIRST™ (MM-020/IFM 07-01) Trial of REVLIMID® (lenalidomide) Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplant Published in New England Journal of Medicine|
|Merrimack Pharmaceuticals Presents Data From Phase 3 NAPOLI-1 Study at the ESMO 16th World Congress on Gastrointestinal Cancer|
|Mood Media sells Canadian account portfolio to Stingray Digital (2014/6/27)|
|New iPhone Faces Risk as Carriers Phase Out Subsidies (2014/9/7)|
|AngioScore Launches New 200 mm Length AngioSculpt(R) Scoring Balloon Catheters|
|Merrimack Pharmaceuticals Announces Initiation of HERMIONE, a Randomized Trial of MM-302 in Patients With Advanced HER2-Positive Breast Cancer to Support Application for Accelerated Approval|
|Vishay Intertechnology Automotive-Grade PIN Photodiodes Deliver High Reverse Light Current to 9.5 µA|
|Vishay Intertechnology VRPower® Integrated DrMOS Power Stages Deliver High Current, Efficiency, and Power Density|
|Astrotech's 1st Detect Unit Introduces Its Latest Technology Breakthrough|
Click above to view more mutual fund data and stats for mms - McMillan Shakespeare Ltd.